Incidental Detection of Radiotracer Uptake in Spindle Cell Lipoma on 18F-PSMA PET/CT

Nir Hod; Yehonatan Sherf; Sophie Lantsberg

doi:10.1097/RLU.0000000000004291

Incidental Detection of Radiotracer Uptake in Spindle Cell Lipoma on ¹⁸F-PSMA PET/CT

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

An 84-year-old man underwent 18F-prostate-specific membrane antigen (PSMA) PET/CT for staging of a newly diagnosed prostate adenocarcinoma. PET/CT revealed high 18F-PSMA uptake in a thigh mass, which was initially suspected for a metastasis. Histopathology revealed a rare entity of spindle cell lipoma, which should be added to the reported list of neoplasms that can show "false-positive"PSMA uptake during evaluation of patients with prostate carcinoma representing a potential interpretative pitfall.

Original language	English
Pages (from-to)	E663-E665
Journal	Clinical Nuclear Medicine
Volume	47
Issue number	10
DOIs	https://doi.org/10.1097/RLU.0000000000004291
State	Published - 1 Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

"false-positive"
F-PSMA
PET/CT
soft tissue tumor
spindle cell lipoma

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1097/RLU.0000000000004291

Cite this

@article{29de27c730f649d38e65573166971249,

title = "Incidental Detection of Radiotracer Uptake in Spindle Cell Lipoma on 18F-PSMA PET/CT",

abstract = "An 84-year-old man underwent 18F-prostate-specific membrane antigen (PSMA) PET/CT for staging of a newly diagnosed prostate adenocarcinoma. PET/CT revealed high 18F-PSMA uptake in a thigh mass, which was initially suspected for a metastasis. Histopathology revealed a rare entity of spindle cell lipoma, which should be added to the reported list of neoplasms that can show {"}false-positive{"}PSMA uptake during evaluation of patients with prostate carcinoma representing a potential interpretative pitfall.",

keywords = "{"}false-positive{"}, F-PSMA, PET/CT, soft tissue tumor, spindle cell lipoma",

author = "Nir Hod and Yehonatan Sherf and Sophie Lantsberg",

note = "Publisher Copyright: {\textcopyright} 2022 Wolters Kluwer Health, Inc.",

year = "2022",

month = oct,

day = "1",

doi = "10.1097/RLU.0000000000004291",

language = "English",

volume = "47",

pages = "E663--E665",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - Incidental Detection of Radiotracer Uptake in Spindle Cell Lipoma on 18F-PSMA PET/CT

AU - Hod, Nir

AU - Sherf, Yehonatan

AU - Lantsberg, Sophie

PY - 2022/10/1

Y1 - 2022/10/1

N2 - An 84-year-old man underwent 18F-prostate-specific membrane antigen (PSMA) PET/CT for staging of a newly diagnosed prostate adenocarcinoma. PET/CT revealed high 18F-PSMA uptake in a thigh mass, which was initially suspected for a metastasis. Histopathology revealed a rare entity of spindle cell lipoma, which should be added to the reported list of neoplasms that can show "false-positive"PSMA uptake during evaluation of patients with prostate carcinoma representing a potential interpretative pitfall.

AB - An 84-year-old man underwent 18F-prostate-specific membrane antigen (PSMA) PET/CT for staging of a newly diagnosed prostate adenocarcinoma. PET/CT revealed high 18F-PSMA uptake in a thigh mass, which was initially suspected for a metastasis. Histopathology revealed a rare entity of spindle cell lipoma, which should be added to the reported list of neoplasms that can show "false-positive"PSMA uptake during evaluation of patients with prostate carcinoma representing a potential interpretative pitfall.

KW - "false-positive"

KW - F-PSMA

KW - PET/CT

KW - soft tissue tumor

KW - spindle cell lipoma

UR - https://www.scopus.com/pages/publications/85137745299

U2 - 10.1097/RLU.0000000000004291

DO - 10.1097/RLU.0000000000004291

M3 - Article

C2 - 35619205

AN - SCOPUS:85137745299

SN - 0363-9762

VL - 47

SP - E663-E665

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 10

ER -